Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: A randomized, placebo controlled trial | Zendy

MARK O. TURNER | Zendy; Patrick Johnston | Zendy; Emílio Pizzichini | Zendy; Marcia MM Pizzichini | Zendy; P Hussack | Zendy; Frederick E. Hargreave | Zendy

Open Access

Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: A randomized, placebo controlled trial

Author(s) -

MARK O. TURNER,

Patrick Johnston,

Emílio Pizzichini,

Marcia MM Pizzichini,

P Hussack,

Frederick E. Hargreave

Publication year - 1998

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/1998/868379

Subject(s) - medicine , salmeterol , sputum , placebo , asthma , randomization , eosinophil cationic protein , exacerbation , randomized controlled trial , eosinophil , gastroenterology , bronchodilator , beclometasone dipropionate , eosinophilic , anesthesia , respiratory disease , lung , tuberculosis , pathology , alternative medicine

Salmeterol is a potent long acting beta-agonist that is effective in relieving the symptoms and airflow limitation of asthma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research